On June 9, Quantinuum rose 5.15% in pre-market trading, trading at $61.24/share, with trading volume of $313,200. The stock had previously fallen below its $60 IPO price on its second trading day.

On the news front, the company disclosed that Director Hal Barron purchased 250,000 shares of Class A common stock on the open market at $60 per share on June 5, totaling $15 million. He was also granted 5,833 restricted stock units set to vest over three years starting June 5 of next year. The substantial insider buying, occurring immediately after the stock broke below its IPO price, was interpreted by the market as a strong confidence signal in the company's long-term prospects.

Quantinuum debuted on the Nasdaq on June 4 after pricing its IPO at $60 per share, raising $1.68 billion through the sale of 28 million shares with over 20x oversubscription. The stock opened up 13% on its first day but closed with only a 0.63% gain before breaking below its offering price the following session amid concerns over widening losses and declining revenue.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)